Intensive initial therapy with triple DMARDs improves functional ability in early rheumatoid arthritis

New research showed that initial therapy with combination DMARDs significantly improves measures of disease activity and functional ability in patients with early rheumatoid arthritis.

Leave a Reply

Your email address will not be published. Required fields are marked *